A Phase 1 trial of ALX-001, an investigational therapy for neurodegenerative conditions, has dosed the first patient with Parkinson’s…
Articles by Patricia Inácio, PhD
Inoviq’s Neuro-Net technology can aid in diagnosing Parkinson’s disease at early stages, with it having effectively isolated and…
The nonprofit SPARK NS has announced the five recipients of the 2024 SPARK NS Parkinson’s Disease Translational Research…
The U.S. Food and Drug Administration (FDA) has agreed on the design of the upcoming Phase 2 SUNRISE-PD clinical trial…
The Parkinson’s Foundation has awarded more than $1 million in 92 community-based grants across 40 states in the U.S. to…
Compounds called polyphenols in the Ecklonia cava seaweed eased motor and nonmotor symptoms in a mouse model of Parkinson’s…
From Monterey Bay in California to Hanalei Bay in Kauai, Hawaii, Team HPP (Human Powered Potential) has rowed 2,800 miles…
Scientists at the University of Florida (UF) have developed an artificial intelligence-powered tool to help neurologists track Parkinson’s disease progression.
Home-based exercise, such as aerobic, strength, or balance exercises, helps relieve overall motor symptoms of Parkinson’s disease, according to…
Scientists have discovered a new regulator — called NHR-49 — that may shed light and open potential new therapeutic avenues…